Tweet
David J. Vaughn, MD; Gretchen A. Gignac, MD; and Anna T. Meadows, MD
http://www.annals.org/cgi/reprint/136/6/463.pdf
Follow up letter by Dr. Tong and a Response by Dr. Vaughn, see page 3
Recommended by dadmo
Testicular cancer is the most common solid tumor diagnosed in men 20 to 35 years of age. Because of highly effective treatments that may include surgery, chemotherapy, and radiation therapy, most patients become long-term survivors. Health-related issues that confront testicular cancer survivors include the late medical effects of chemotherapy, the late relapse of disease, the development of second cancers, the effect of the disease and treatment on fertility, and the psychosocial consequences. This case-based discussion focuses on the primary care physician’s evaluation and management of a long-term survivor of testicular cancer who was previously treated with surgery and chemotherapy.
Ann Intern Med. 2002;136:463-470.
Ann Intern Med. 2002;136:463-470.
Follow up letter by Dr. Tong and a Response by Dr. Vaughn, see page 3
Recommended by dadmo